Skip to content
  • LinkedIn

The Business of Biofabrication

  • News
  • Perspectives
  • Learn
  • Landscape

Markets

  • TISSIUM’s COAPTIUM Connect ushers in photopolymer 3‑D printing for implantables
    July 23, 2025

    TISSIUM’s COAPTIUM Connect ushers in photopolymer 3‑D printing for implantables

    Ricky Solorzano
  • CollPlant Expands U.S. Footprint with Strategic Hire to Lead Commercial GrowthBusiness of Biofabrication
    July 16, 2025

    CollPlant Expands U.S. Footprint with Strategic Hire to Lead Commercial GrowthBusiness of Biofabrication

    Ricky Solorzano
  • Tissue Regenix recent results and what to watch
    July 10, 2025

    Tissue Regenix recent results and what to watch

    Ricky Solorzano
  • Vertex’s Zimislecel Shows Early Promise for Insulin Independence
    July 2, 2025

    Vertex’s Zimislecel Shows Early Promise for Insulin Independence

    Ricky Solorzano
  • 3DBioFibR Secures $3M to Scale High-Performance Biopolymer Fiber Manufacturing
    June 26, 2025

    3DBioFibR Secures $3M to Scale High-Performance Biopolymer Fiber Manufacturing

    William Ernst
  • Biofabricated Organ Support: miroliverELAP’s First Human Treatment for Acute Liver Failure
    June 25, 2025

    Biofabricated Organ Support: miroliverELAP’s First Human Treatment for Acute Liver Failure

    Ricky Solorzano
  • Vivodyne Raises $40M to Scale AI and Robotics-Driven Human Tissue Platform for Drug Discovery
    June 4, 2025

    Vivodyne Raises $40M to Scale AI and Robotics-Driven Human Tissue Platform for Drug Discovery

    William Ernst
  • VivoSim Labs Introduces NAMkind Platform for Human-Based Drug Testing Models
    May 6, 2025

    VivoSim Labs Introduces NAMkind Platform for Human-Based Drug Testing Models

    Ricky Solorzano
  • Organovo Rebrands as VivoSim Labs to Advance 3D Bioprinting Technology
    April 27, 2025

    Organovo Rebrands as VivoSim Labs to Advance 3D Bioprinting Technology

    Ricky Solorzano
  • Organovo Sells FXR Drug Program to Eli Lilly in Strategic Deal to Advance IBD Therapies
    April 3, 2025

    Organovo Sells FXR Drug Program to Eli Lilly in Strategic Deal to Advance IBD Therapies

    Ricky Solorzano
Previous Page
1 2 3 4 5
Next Page

Archives

To make sense of, stay update on, and learn about
the business of biofabrication

Subscribe

2024 All Rights Reserved

  • Subscribe Subscribed
    The Business of Biofabrication

    Have a WordPress.com account? Log in now.

  • The Business of Biofabrication
    View site in Reader
    Manage subscriptionsSign upLog in
    Report this content
    Collapse this bar